Drugs / Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets)
Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03604159 Comparator | Jun 2019 → May 2020 | opiate dependence | NYU Langone Health | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03604159 ↗ |